Nature's Sunshine Products Inc. logo

Nature's Sunshine Products Inc. (NATR)

Market Closed
10 Sep, 20:00
NASDAQ (CM) NASDAQ (CM)
$
13. 61
-0.05
-0.366%
Pre Market
$
14. 35
+0.74 +5.4372%
243.02M Market Cap
24.29 P/E Ratio
- Div Yield
138,869 Volume
0.84 Eps
$ 13.66
Previous Close
Analysts:
Add Transaction
Day Range
13.52 13.94
Year Range
12.97 28.14
Want to track NATR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Nature's Sunshine Targets $1B Sales, 15% EBITDA Margin in Growth Push

Nature's Sunshine Targets $1B Sales, 15% EBITDA Margin in Growth Push

Nature's Sunshine Products NASDAQ: NATR outlined a strategy to double sales to $1 billion and expand EBITDA margins to 15%, with Chief Executive Officer Ken Romanzi pointing to geographic expansion, digital and retail channel development, marketing initiatives and acquisitions as the company's primary growth drivers.

Marketbeat | 3 weeks ago
Nature's Sunshine Products, Inc. (NATR) Q2 2026 Earnings Call Transcript

Nature's Sunshine Products, Inc. (NATR) Q2 2026 Earnings Call Transcript

Nature's Sunshine Products, Inc. (NATR) Q2 2026 Earnings Call Transcript

Seekingalpha | 1 month ago
Nature's Sunshine Products Q2 Earnings Call Highlights

Nature's Sunshine Products Q2 Earnings Call Highlights

Nature's Sunshine Products NASDAQ: NATR reported second-quarter net sales of $117 million, its strongest second quarter in company history, as digital growth in North America and continued momentum across much of Asia-Pacific and Europe supported results.

Marketbeat | 1 month ago
Nature's Sunshine Products Q1 Earnings Call Highlights

Nature's Sunshine Products Q1 Earnings Call Highlights

Nature's Sunshine Products NASDAQ: NATR reported what management called a “very strong” start to 2026, highlighting first-quarter sales growth of 9% and adjusted EBITDA growth of 33% as the company continued to push deeper into digital channels and subscription programs while expanding its consultant base globally.

Marketbeat | 4 months ago
Nature's Sunshine Products, Inc. (NATR) Q1 2026 Earnings Call Transcript

Nature's Sunshine Products, Inc. (NATR) Q1 2026 Earnings Call Transcript

Nature's Sunshine Products, Inc. (NATR) Q1 2026 Earnings Call Transcript

Seekingalpha | 4 months ago
Nature's Sunshine Products, Inc. (NATR) Q4 2025 Earnings Call Transcript

Nature's Sunshine Products, Inc. (NATR) Q4 2025 Earnings Call Transcript

Nature's Sunshine Products, Inc. (NATR) Q4 2025 Earnings Call Transcript

Seekingalpha | 6 months ago
Nature's Sunshine Looks Fairly Priced After Its Recent Rally

Nature's Sunshine Looks Fairly Priced After Its Recent Rally

Nature's Sunshine delivered strong Q3 2025 results, driven by robust growth in Asia and recurring autoship sales. NATR's international focus, especially in Asia and Europe, positions it for continued growth, though its MLM model may cause choppy performance. Despite a strong balance sheet, buybacks, and premium margins, NATR's current valuation reflects its strengths, and it trades at a premium to other MLMs.

Seekingalpha | 9 months ago
Nature's Sunshine Products, Inc. (NATR) Q3 2025 Earnings Call Transcript

Nature's Sunshine Products, Inc. (NATR) Q3 2025 Earnings Call Transcript

Nature's Sunshine Products, Inc. ( NATR ) Q3 2025 Earnings Call November 6, 2025 5:00 PM EST Company Participants Nathan Brower - Executive VP, General Counsel & Secretary Kenneth Romanzi - CEO & Director Shane Jones - Executive VP of Finance, CFO & Treasurer Conference Call Participants Brian Holland - D.A. Davidson & Co., Research Division Presentation Operator Good afternoon, everyone, and thank you for participating in today's conference call to discuss Nature's Sunshine's financial results for the third quarter ended September 30, 2025.

Seekingalpha | 10 months ago
Nature's Sunshine: Premium Valuation Without Moats, Sell

Nature's Sunshine: Premium Valuation Without Moats, Sell

Nature's Sunshine is a leading U.S.-based herbal supplement manufacturer founded in 1972, operating a Multi-Level Marketing model. Nature's Sunshine (NATR) is trading at a 16.4x forward P/E, a premium compared to the peer average of 14.2x, and higher than companies like Herbalife (4.1x) and USANA (11.2x). The company's forward revenue growth of 2.8% and mixed EPS outlook do not justify the premium valuation, especially when compared to competitors like LifeVantage, which has a 26.6% CAGR EPS.

Seekingalpha | 1 year ago
Nature's Sunshine Products, Inc. (NATR) Q2 2025 Earnings Call Transcript

Nature's Sunshine Products, Inc. (NATR) Q2 2025 Earnings Call Transcript

Nature's Sunshine Products, Inc. (NASDAQ:NATR ) Q2 2025 Earnings Conference Call July 31, 2025 5:00 PM ET Company Participants L. Shane Jones - Executive VP of Finance, CFO & Treasurer Nathan G.

Seekingalpha | 1 year ago
Nature's Sunshine Products, Inc. (NATR) Q1 2025 Earnings Call Transcript

Nature's Sunshine Products, Inc. (NATR) Q1 2025 Earnings Call Transcript

Nature's Sunshine Products, Inc. (NASDAQ:NATR ) Q1 2025 Earnings Conference Call May 6, 2025 5:00 PM ET Company Participants Terrence Moorehead - CEO Shane Jones - CFO Nate Brower - General Counsel Conference Call Participants Brian Holland - Davidson Susan Anderson - Canaccord Genuity Operator Good afternoon, everyone. And thank you for participating in today's conference call to discuss Nature's Sunshine's Financial Results for the First Quarter Ended March 31, 2025.

Seekingalpha | 1 year ago
Nature's Sunshine Products: Near-Term Weakness But Attractive Entry Point For Long-Term Investors

Nature's Sunshine Products: Near-Term Weakness But Attractive Entry Point For Long-Term Investors

Nature's Sunshine Products offers a compelling long-term investment opportunity, trading at a 35% discount to historical averages. Despite weak North American demand, NATR's digital strategies and Asia-Pacific market success, particularly in Taiwan, Japan, and Korea, should sustain revenue growth. Margins are expected to remain flat or slightly down in FY2025 due to inflationary pressures, but cost-saving initiatives should provide some relief.

Seekingalpha | 1 year ago
Loading...
Load More